Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1):results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Autor: András Temesvári, Sigita Aidietienė, Vladimir M. Shipulin, Jae Seung Lee, Pavel Jansa, Nuofu Zhang, Dominik Richard, Nguyen Vinh Pham, Carlos Jerjes Sanchez, Lan Hieu Nguyen, Keertan Dheda, Christian M. Kähler, Olga Barbarash, Piotr Podolec, Tomas Rene Pulido Zamudio, Michael M. Madani, Hyung Kwan Kim, Suree Sompradeekul, Grégoire Prévot, Silvia Ulrich, Luke Howard, Nattapong Jaimchariyatam, Olga Moiseeva, Gulfer Okumus, Zoheir Bshouty, Arintaya Phrommintikul, Friedrich Grimminger, David P. Jenkins, Heinrike Wilkens, Robin Condliffe, Irene Lang, John-David Aubert, Rudolf Speich, Tatiana Mularek-Kubzdela, Nicolas Martin, Hélène Bouvaist, Stephan Rosenkranz, Jun Bean Park, Peter F. Fedullo, Luke S. Howard, Olivier Sanchez, Gérald Simonneau, Ryszard Grzywna, Alexander Chernyavskiy, Zhi-Cheng Jing, Joanna Pepke-Zaba, Anton Vonk Noordegraaf, Andrea Maria D'Armini, Pablo Sepulveda Varela, Gang-Cheng Zhang, Nick H. Kim, Eckhard Mayer, Jerzy Lewczuk, Yuhong Mi, Zeynep Pinar Onen, Ekkehard Grünig, Xian-Yang Zhu, Marion Delcroix, John McConnell, Yuanhua Yang, Jin-Ming Liu, Lyubomyr Solovey, Kelly Papadakis, Xavier Jaïs, Istvan Edes, Tamila Vitalievna Martynyuk, Matthias Held, Kristóf Karlócai, Jarosław Kasprzak, Skaidrius Miliauskas, Hossein Ardeschir Ghofrani, Kim M. Kerr, Volodymyr Gavrysyuk

Publikováno v: Ghofrani, H A, Simonneau, G, D'Armini, A M, Fedullo, P, Howard, L S, Jaïs, X, Jenkins, D P, Jing, Z C, Madani, M M, Martin, N, Mayer, E, Papadakis, K, Richard, D, Kim, N H, Noordegraaf, A V & MERIT study investigators 2017, ' Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1) : results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study ', The Lancet Respiratory Medicine, vol. 5, no. 10, pp. 785-794 . https://doi.org/10.1016/S2213-2600(17)30305-3
The Lancet Respiratory Medicine, 5(10), 785-794. Elsevier Limited

Summary Background Macitentan is beneficial for long-term treatment of pulmonary arterial hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension are similar. Methods The phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36794781d5eccbc59c72cb8cc5a212e5
https://research.vumc.nl/en/publications/4d05f687-13a9-445c-ba49-7129684838f4

Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?

Autor: Oznur, Akkoca Yildiz, Zeynep Pinar, Onen, Gizem, Demir, Banu, Eriş Gülbay, Sevgi, Saryal, Gülseren, Karabiyikoğlu

Publikováno v: Tuberkuloz ve toraks. 54(2)

The effects of anticholinergic agents or long acting beta(2)-agonists on exercise capacity in chronic obstructive pulmonary disease (COPD) improves various out come measures but there is not enough double-blind study which included comparison of diff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d21c76d7cc34c31f2fd6579e459bb3a8
https://pubmed.ncbi.nlm.nih.gov/16924565

Management of chronic Pseudomonas aeruginosa infection and ventilatory failure in Kartagener's syndrome: Case report

Autor: Sen, Elif, Kaya, Akin, Yalcin, Aslihan, Zeynep Pinar Onen, Gulbay, Banu, Kumbasar, Ozlem Ozdemir

Publikováno v: Scopus-Elsevier
Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bcbaf601664621fda2c07651fb00bc00
http://www.scopus.com/inward/record.url?eid=2-s2.0-76749151955&partnerID=MN8TOARS